Hunting Hill Global Capital, LLC Takeda Pharmaceutical CO LTD Transaction History

Hunting Hill Global Capital, LLC

  • $101 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$13.02 - $20.31 $3.56 Million - $5.56 Million
-273,772 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$16.15 - $17.99 $968,999 - $1.08 Million
-60,000 Reduced 17.98%
273,772 $4.71 Million
Q1 2019

May 15, 2019
BUY
$16.7 - $21.52 $5.57 Million - $7.18 Million
333,772 New
333,772 $6.8 Million

Others Institutions Holding TAK

# of Institutions
336
Shares Held
73.8M
Call Options Held
1.96M
Put Options Held
165K
View Full List

About TAKEDA PHARMACEUTICAL CO LTD

TAK Quotes by TradingView
  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $41.6B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Hunting Hill Global Capital, LLC Portfolio

Follow Hunting Hill Global Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hunting Hill Global Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hunting Hill Global Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email